Impact of CYP3A4*18 and CYP3A5*3 Polymorphisms on Imatinib Mesylate Response Among Chronic Myeloid Leukemia Patients in Malaysia
Crossref DOI link: https://doi.org/10.1007/s40487-016-0035-x
Published Online: 2016-11-21
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Maddin, Najlaa
Husin, Azlan
Gan, Siew Hua
Aziz, Baba Abdul
Ankathil, Ravindran
Funding for this research was provided by:
Universiti Sains Malaysia (1001/PPSP/812103)